GEM and neoplasm: Along with these shifts in the immune landscape, we also identified decreased tumor cell proliferation as evidenced by reduced Ki67+ staining and enhanced apoptosis in the Gem+ICB+CCR2i compared with the Gem and Gem+ICB groups (Figure 6, C and D).